Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Additional manufacturing site for COVID-19 Vaccine Janssen 7 October 2021NewsHumanCOVID-19 Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 October 2021NewsHumanCOVID-19 EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 October 2021NewsHumanCOVID-19Medicines EMA welcomes new Head of International Affairs 1 October 2021NewsCorporateCareersGovernance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 1 October 2021NewsHumanCOVID-19Pharmacovigilance EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 October 2021NewsHumanPharmacovigilanceReferrals Transatlantic Taskforce continues international fight against antimicrobial resistance 30 September 2021NewsHumanVeterinaryAntimicrobial resistanceClinical trials EMA implements new measures to minimise animal testing during medicines development 29 September 2021NewsHumanVeterinaryCorporateInnovation EMA evaluating data on booster dose of COVID-19 vaccine Spikevax 27 September 2021NewsHumanCOVID-19Medicines Call for expressions of interest for civil society representatives to participate in work of Committee for Advanced Therapies 24 September 2021News 1 … 54 55 56 57 58 Page 58 of 380 59 60 61 62 … 380
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 October 2021NewsHumanCOVID-19
EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 October 2021NewsHumanCOVID-19Medicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 1 October 2021NewsHumanCOVID-19Pharmacovigilance
EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 October 2021NewsHumanPharmacovigilanceReferrals
Transatlantic Taskforce continues international fight against antimicrobial resistance 30 September 2021NewsHumanVeterinaryAntimicrobial resistanceClinical trials
EMA implements new measures to minimise animal testing during medicines development 29 September 2021NewsHumanVeterinaryCorporateInnovation
EMA evaluating data on booster dose of COVID-19 vaccine Spikevax 27 September 2021NewsHumanCOVID-19Medicines
Call for expressions of interest for civil society representatives to participate in work of Committee for Advanced Therapies 24 September 2021News